New safety recommendations issued for ketorolac.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D003257:Consumer Product Safety; D000075202:Contraindications; D006801:Humans; D020910:Ketorolac; D011356:Product Labeling; D011358:Product Surveillance, Postmarketing; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D014046:Tolmetin; D020910:Ketorolac